News
GoodRx is a compelling small-cap value play with stabilizing growth, expanding pharma partnerships, and potential acquisition ...
Hosted on MSN9mon
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2024 Earnings Call TranscriptGoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2024 Earnings Call Transcript August 8, 2024 GoodRx Holdings, Inc. misses on earnings expectations. Reported EPS is $0.04314 EPS, expectations were $0.09 ...
Get the annual and quarterly balance sheet of GoodRx Holdings, Inc. (GDRX) including details of assets, liabilities and shareholders' equity.
“We shared this information with third parties, including Facebook. In some cases, GoodRx used the information to target people with health-related ads.” The alert comes a month after the FTC ...
Insurance challenges leave millions of Americans frustrated when trying to fill prescriptions. The bureaucratic obstacles not only exacerbate delays, but often translate to more of the cost burden ...
GoodRx is adding insurance coverage information to its drug cost estimation platform for providers, in what the California-based digital health company says is a key differentiator for the fast ...
It also shows just how leaky some of these services, which we entrust with our most private information, can be. The FTC alleges that GoodRx shared the names of medications users were looking for ...
make sure your personal information (address, email, phone) is updated with your state’s Medicaid agency. Not sure how to reach your Medicaid agency? No problem. GoodRx is here to help with ...
According to new Federal Trade Commission allegations, however, GoodRx ostensibly lied to over 55 million users by surreptitiously selling deeply personal medical information to companies as large ...
"We shared this information with third parties, including Facebook. In some cases, GoodRx used the information to target people with health-related ads." The alert comes a month after the FTC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results